Document Detail

Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men.
MedLine Citation:
PMID:  10904025     Owner:  NLM     Status:  MEDLINE    
The physiological effects of angiotensin-converting enzyme (ACE) inhibition may be in part mediated by bradykinin. We investigated the effect of coadministration of the specific bradykinin B(2) receptor antagonist icatibant on hemodynamic and neurohormonal responses to acute intravenous ACE inhibition in normal men on a normal sodium diet. We performed a 4-phase, double-blind, double-dummy, placebo-controlled study in 12 male volunteers. The bradykinin antagonist icatibant (10 mg IV) was coadministered over the first 15 minutes of a 2-hour infusion of the ACE inhibitor perindoprilat (1.5 mg IV). Perindoprilat inhibited ACE activity and elicited the expected changes in active renin concentration and angiotensin peptides. Over the 3 hours after the start of drug infusion, perindoprilat lowered and icatibant increased mean arterial blood pressure (each P<0.0005 versus placebo). Coadministration of icatibant attenuated the mean arterial blood pressure response to perindoprilat (P<0.0005) but had no effect on neurohormonal responses to perindoprilat. Our study indicates that the bradykinin B(2) receptor antagonist icatibant attenuates the short-term blood pressure-lowering effect of acute ACE inhibition in normal men on a normal sodium diet. Bradykinin B(2) receptor antagonism alone increases resting blood pressure. Bradykinin may be involved in the control of blood pressure in the resting state in humans.
I B Squire; K P O'Kane; N Anderson; J L Reid
Related Documents :
358295 - The effect of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrhei...
3779405 - Cryogenic blockade of the central nucleus of the amygdala attenuates aversively conditi...
18605985 - Rna interference targeting the ace gene reduced blood pressure and improved myocardial ...
3534845 - Low dose captopril twice daily lowers blood pressure without disturbance of the normal ...
10362055 - Changes in airway resistance induced by nasal or oral intermittent positive pressure ve...
11566965 - Evaluation of the blood pressure load in the diagnosis of hypertension in pregnancy.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hypertension     Volume:  36     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:  2000 Jul 
Date Detail:
Created Date:  2000-10-06     Completed Date:  2000-10-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  132-6     Citation Subset:  IM    
Department of Medicine & Therapeutics, University of Glasgow, Glasgow, Scotland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Angiotensins / blood
Area Under Curve
Blood Pressure / drug effects*
Bradykinin / analogs & derivatives*,  pharmacology,  physiology
Double-Blind Method
Peptidyl-Dipeptidase A / blood
Receptor, Bradykinin B2
Receptors, Bradykinin / antagonists & inhibitors*
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Angiotensins; 0/Receptor, Bradykinin B2; 0/Receptors, Bradykinin; 130308-48-4/icatibant; 58-82-2/Bradykinin; EC A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibito...
Next Document:  Hypertension risk status and effect of caffeine on blood pressure.